Acer Medical Inc.

Taipei Exchange:6857.TWO

Sector

🏥 Health Care

Industries

🤖 Artificial Intelligence (AI)

📊 Big Data

🔬 Clinical Trials

🏥 Hospitals & Clinics

💻 Telehealth

Location

Taiwan

Market Cap

USD 65.59 M

Share Price

USD 4.31

Avg Daily Volume

3,093

Change (1 day)

0.11%

Change (1 year)

-19.68%

Change (YTD)

-0.53%

Acer Medical Inc. EBITDA for the year ending December 31, 2024: USD -882.07 K

Acer Medical Inc. EBITDA is USD -882.07 K for the year ending December 31, 2024, a -32.05% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.

Acer Medical Inc. EBITDA for the year ending December 31, 2023 was USD -1.30 M, a -26.99% change year over year.
Acer Medical Inc. EBITDA for the year ending December 31, 2022 was USD -1.78 M, a 141.95% change year over year.
Acer Medical Inc. EBITDA for the year ending December 31, 2021 was USD -734.83 K, a 74.64% change year over year.
Acer Medical Inc. EBITDA for the year ending December 31, 2020 was USD -420.76 K.

Quarterly
Annual
TTM

From:

To:

Zoom:

Key data

Date	EBITDA	Net Income	EPS (Diluted)	Shares (Diluted, Weighted)

Taipei Exchange: 6857.TWO

Acer Medical Inc.

CEO	Mr. Yin Xiong Xu
IPO Date	March 4, 2022
Location	Taiwan
Headquarters	No. 88, Section 1, Xintai 5th Road
Employees	22
Sector	🏥 Health Care
Industries Artificial Intelligence (AI) 📊 Big Data 🔬 Clinical Trials 🏥 Hospitals & Clinics 💻 Telehealth

Description

Acer Medical Inc. offers artificial intelligence, clinical data, and software for healthcare sector. It offers VeriSee DR, an AI-assisted diagnostic software for diabetic retinopathy identification; VeriSee AMD, an AI-assisted screening software for age-related macular degeneration identification; and VeriOsteo OP, an AI-assisted screening software for bone mineral density abnormalities. Acer Medical Inc. was founded in 2018 and is based in New Taipei City, Taiwan.